The FDA has granted Endologix expanded approval for its AFX endovascular system used to treat abdominal aortic aneurysms, along with the company's IntuiTrak Powerlink technology. The device is now approved for use in percutaneous endovascular aneurysm repair procedures and could be available for physician training in the U.S. as early as the second quarter.
FDA widens approval for Endologix's aneurysm repair device
SmartBrief Job Listings for Health Care
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan